Acquired vs inherited bone marrow failure

When the marrow stops keeping up, the cause matters

Bone marrow failure means the marrow is not making enough red cells, white cells or platelets to meet the body's needs. That single sentence covers a surprisingly wide family of conditions. Some arrive in adulthood after the immune system turns on the marrow. Others are written into a person's genes and may show up in a toddler, a teenager, or occasionally a 50-year-old.

This page sets out the two big groups, acquired and inherited, and the main conditions inside each. It also explains why doctors work so hard to tell them apart, and which tests they use. The most common form, aplastic anaemia (spelled "anemia" in the US), sits in the acquired group, but it can sometimes turn out to have an inherited cause. That overlap is the reason this topic deserves its own page.

Nothing here replaces the judgement of your haematology team, who can see your blood counts, your history and your family. Think of it as a map to bring to those conversations.

What "bone marrow failure syndrome" actually means

You will see the phrase used in two ways. In everyday clinic talk, "bone marrow failure" is the broad umbrella: low blood counts because the marrow is underperforming. "Bone marrow failure syndrome" is more often used for the inherited conditions specifically. Cleveland Clinic makes the same split, describing two types, acquired and inherited, and noting that doctors call the inherited type a bone marrow failure syndrome.

Symptoms look much alike either way. Tiredness, paleness, breathlessness, frequent infections, easy bruising and bleeding are the usual ones, because they follow directly from low red cells, white cells and platelets. The difference lies underneath, in why the marrow is struggling. If you want the basics of how healthy marrow works first, how bone marrow makes blood covers it.

Timing offers a loose clue but no more. Cleveland Clinic notes that inherited forms may start showing symptoms from around age 2, while acquired forms often appear between ages 20 and 25 or after 65. Plenty of people fall outside those windows.

Acquired causes

Acquired means the marrow was built normally and something damaged or suppressed it later. In most people with aplastic anaemia, the best-supported explanation is autoimmune: the immune system mistakenly targets blood-forming stem cells. A NIH-linked review calls immune aplastic anaemia the commonest form of marrow failure and describes it as a diagnosis of exclusion, meaning the other possibilities have to be ruled out first (a clinical review from the US National Institutes of Health).

Immune aplastic anaemia and the PNH overlap

Immune attack is the leading mechanism, and it is why treatment often centres on calming the immune system (see immunosuppressive therapy). Many people with aplastic anaemia also carry small populations of cells with the PNH defect. Paroxysmal nocturnal haemoglobinuria can exist alongside marrow failure, and the two sometimes blur into each other. Even so, in the Dutch children's study, PNH clones turned up in only four of 50 patients, and three of those were tiny, between 0.1% and 1% (a Dutch prospective study of 50 children). Children and adults differ here, and adults are more likely to show a PNH clone.

Drugs, chemicals, radiation and viruses

Cleveland Clinic lists several outside triggers that can raise the risk of acquired failure: chemotherapy and radiation therapy given for cancer, and exposure to chemicals and solvents found in some insecticides and pesticides. Certain viral infections are also on its list, including cytomegalovirus, Epstein-Barr virus, HIV, parvovirus B19 and viral hepatitis. In many cases no trigger is ever found, which doctors label idiopathic.

Myelodysplastic syndromes

Myelodysplastic syndromes (MDS) are clonal disorders of the marrow, and Cleveland Clinic includes them among the conditions that raise the risk of marrow failure. They matter here because low counts from MDS can look very like aplastic anaemia on a first blood test. A bone marrow biopsy and chromosome analysis help separate them, which is covered in diagnosing bone marrow failure.

Inherited bone marrow failure syndromes

Inherited syndromes arise from gene changes passed down from one or both parents, or occasionally arising newly in the person. Cleveland Clinic gives an overall figure of 65 in 1 million babies born in the US each year with an inherited disorder that causes bone marrow failure, so they are rare but not vanishingly so. Several of the best known have their own pages here.

Fanconi anaemia

Fanconi anaemia is described by Cleveland Clinic as the most common inherited marrow failure syndrome, affecting 1 to 5 in 1 million people. The underlying problem is faulty repair of damaged DNA, which leaves blood stem cells accumulating damage. Dana-Farber Cancer Institute notes that people with it also face a higher risk of certain cancers and need routine screening from physicians who know the condition.

Dyskeratosis congenita and telomere biology disorders

Dyskeratosis congenita belongs to a wider group called telomere biology disorders. Telomeres are the protective caps at the ends of chromosomes, and in these conditions they are abnormally short. Dana-Farber describes possible changes to nails, skin and the lining of the mouth, plus a higher risk of blood cancers, lung scarring and liver disease. Because the signs can be subtle, some people are only diagnosed once marrow failure appears.

Shwachman-Diamond syndrome

Shwachman-Diamond syndrome typically brings low white cell counts, frequent infections and poor growth because the pancreas does not absorb food properly. Dana-Farber points out that most people are diagnosed very early in life but that adult diagnoses happen too.

Diamond-Blackfan anaemia and others in brief

Diamond-Blackfan anaemia mainly affects red cell production. Most people are diagnosed very early and need red cell transfusions, so iron overload becomes a long-term concern. Dana-Farber also lists GATA2-related disorders, which bring low counts, frequent infections and a higher blood cancer risk, and SAMD9 and SAMD9L-related disorders. Cleveland Clinic names severe congenital neutropenia, congenital amegakaryocytic thrombocytopenia and others. Pure red cell aplasia also shows up in these lists, though it has both inherited and acquired versions.

Acquired and inherited side by side

The table shows tendencies, not rules. Some inherited cases look exactly like immune aplastic anaemia, and some acquired cases have unusual features.

Why telling them apart changes everything

A haematology education review opens with a blunt statement: the treatment and medical management of aplastic anaemia differ fundamentally between inherited and acquired marrow failure, yet an inherited syndrome is often hard to spot. Four decisions turn on getting it right.

Treatment choice

Immunosuppressive treatment makes sense when the immune system is the culprit. It is not designed for a marrow damaged by a genetic fault, so a missed inherited diagnosis can mean time spent on a treatment that will not help. The NIH-linked review does stress, though, that treatment for people who clearly have immune severe aplastic anaemia need not be held up while waiting for specialist or genetic results.

Choosing a family donor

If a transplant is planned, a brother or sister is often the first donor considered. But a sibling might carry the same gene change without showing signs of it yet. Testing before donation protects both people. See stem cell transplant for aplastic anaemia for how donors are matched.

Cancer surveillance

Inherited syndromes often carry a raised long-term risk of leukaemia, MDS or solid tumours. Dana-Farber describes surveillance built from routine blood counts, bone marrow assessments and blood molecular sequencing, tailored to each condition. A person diagnosed correctly can be monitored correctly.

Family planning and relatives

Cleveland Clinic explains the inheritance odds in plain terms. If one parent has an autosomal dominant condition, a child has a 50% chance of inheriting it. If both parents carry the same recessive change but neither is affected, the chance for each child is 25%. A confirmed diagnosis lets relatives be tested and lets couples ask a genetics team about their options.

How doctors screen for an inherited cause

The work starts with history: age at onset, family blood problems, early cancers, and physical clues such as nail changes or short stature. After that, a few targeted tests do most of the sorting.

• Chromosome breakage testing, where blood cells are exposed to a DNA-damaging chemical and checked for breaks, screens for Fanconi anaemia. The Dutch study used mitomycin C for this.
• Telomere length measurement by flow FISH screens for telomere biology disorders. A short length points toward dyskeratosis congenita and related conditions.
• Genetic panels or exome sequencing look for changes in the many genes linked to marrow failure.

How well does it work? In the Dutch study of 50 children, a full work-up found a likely cause in 20 (40%), while 30 (60%) stayed unexplained. Among children who also had non-blood abnormalities such as facial differences or developmental delay, a diagnosis was reached in 9 of 12 (75%). Among those with blood findings only, it was 11 of 38 (29%) (a Dutch prospective study of 50 children). The NIH-linked review adds that people with normal telomere length and no suspicious clinical features are unlikely to have constitutional marrow failure, with a specificity above 90% in its machine learning model (a clinical review from the US National Institutes of Health).

Results can also come back as a "variant of uncertain significance", a gene change nobody can yet label harmless or harmful. Reading those takes a clinical geneticist. Our page on diagnosing bone marrow failure describes the first-line tests in more detail.

Adults can have inherited forms too

It is easy to assume that anything genetic must show up in childhood. It does not always. Dana-Farber runs a dedicated adult programme because some people are first diagnosed as adults, and it names Shwachman-Diamond syndrome as one that can be found late. Milder gene changes, or ones that only shorten telomeres gradually, can stay quiet for decades.

For this reason, many haematologists consider the possibility of an inherited cause in younger adults, in anyone with a family history of low counts, early cancer or lung or liver disease, and in anyone whose response to treatment is unusual. If any of that rings true, mention it at your next appointment. A future page may cover genetic counselling and support in more depth.

What to take away

Bone marrow failure is a group of conditions with one visible result, low blood counts, and several possible roots. The acquired group, led by immune aplastic anaemia, responds to treatments aimed at the immune system. The inherited group needs its own approach, including careful donor selection, long-term cancer monitoring and family testing. Because the two can look alike, a thorough early work-up is not over-caution. It decides which path you walk, and a few simple tests can settle the question for many families.